Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1811-1820 of 2919 for cancer

Edit search filters
  1. Study Of TH-302 Or Placebo In Combination With Pemetrexed In Patients With Non-squamous Non-small Cell Lung Cancer

    Rochester, MN

  2. PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine In Subjects With Stage IV Untreated Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  3. Olaparib And Atezolizumab Either Alone Or In Combination In Treating Patients With Stage III-IV Triple Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Maintenance Chemotherapy With Or Without Stereotactic Body Radiation Therapy In Treating Patients With Stage IV Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. Phase 1b Safety Study Of CMB305 In Patients With Locally Advanced, Relapsed, Or Metastatic Cancer Expressing NY-ESO-1

    Rochester, MN

  6. The Role Of Highly Selective Androgen Receptor (AR) Targeted Therapy In Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    Scottsdale/Phoenix, AZ

  7. A Study Comparing Orteronel Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer, Who Have Not Had Chemotherapy

    Jacksonville, FL, Rochester, MN

  8. A Study Of Cabiralizumab Given With Nivolumab With And Without Chemotherapy In Patients With Advanced Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  9. Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With Or Without Bevacizumab In Previously Untreated Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ

  10. Once-daily Oral VT-464 In Patients With Castration-Resistant Prostate Cancer Progressing On Enzalutamide Or Abiraterone.

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer